What is it about?

We developed novel nanoparticles able to deliver cholesterol into the brain. The study is the initial charaterisation of the new nanocarriers and evaluates safety and toxicity.

Featured Image

Read the Original

This page is a summary of: Hybrid nanoparticles as a new technological approach to enhance the delivery of cholesterol into the brain, International Journal of Pharmaceutics, May 2018, Elsevier,
DOI: 10.1016/j.ijpharm.2018.03.061.
You can read the full text:

Read

Contributors

The following have contributed to this page